Activation of the P2X7 receptor and NLRP3-dependent IL-1β production by dendritic cells is important for priming of T cells, and this pathway was shown to regulate CD8+ T cell activity in the anti-cancer immune response (185) and Th17 differentiation in arthritis models (181). The gene discussed is NLRP3; the disease is cancer.